vs
Side-by-side financial comparison of Dexcom (DXCM) and UPBOUND GROUP, INC. (UPBD). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× UPBOUND GROUP, INC.). Dexcom runs the higher net margin — 21.2% vs 1.7%, a 19.6% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 10.9%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 4.5%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Upbound Group, Inc. is a leading US provider of flexible lease-to-own solutions for consumer goods. It offers furniture, consumer electronics, home appliances, and accessories, catering to customers seeking accessible payment alternatives to traditional retail financing.
DXCM vs UPBD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $267.3M | $19.7M |
| Gross Margin | 62.9% | 49.0% |
| Operating Margin | 25.6% | 4.8% |
| Net Margin | 21.2% | 1.7% |
| Revenue YoY | 21.6% | 10.9% |
| Net Profit YoY | 153.6% | -36.3% |
| EPS (diluted) | $0.67 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.0B | $1.2B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $994.2M | $1.1B | ||
| Q2 24 | $1.0B | $1.1B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $19.7M | ||
| Q3 25 | $283.8M | $13.2M | ||
| Q2 25 | $179.8M | $15.5M | ||
| Q1 25 | $105.4M | $24.8M | ||
| Q4 24 | $151.7M | $31.0M | ||
| Q3 24 | $134.6M | $30.9M | ||
| Q2 24 | $143.5M | $33.9M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 49.0% | ||
| Q3 25 | 60.5% | 48.3% | ||
| Q2 25 | 59.5% | 49.4% | ||
| Q1 25 | 56.9% | 46.8% | ||
| Q4 24 | 58.9% | 47.1% | ||
| Q3 24 | 59.7% | 47.8% | ||
| Q2 24 | 62.4% | 49.4% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 4.8% | ||
| Q3 25 | 20.1% | 4.5% | ||
| Q2 25 | 18.4% | 4.4% | ||
| Q1 25 | 12.9% | 5.3% | ||
| Q4 24 | 17.0% | 7.3% | ||
| Q3 24 | 15.3% | 6.6% | ||
| Q2 24 | 15.7% | 7.5% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 1.7% | ||
| Q3 25 | 23.5% | 1.1% | ||
| Q2 25 | 15.5% | 1.3% | ||
| Q1 25 | 10.2% | 2.1% | ||
| Q4 24 | 13.6% | 2.9% | ||
| Q3 24 | 13.5% | 2.9% | ||
| Q2 24 | 14.3% | 3.2% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.35 | ||
| Q3 25 | $0.70 | $0.22 | ||
| Q2 25 | $0.45 | $0.26 | ||
| Q1 25 | $0.27 | $0.42 | ||
| Q4 24 | $0.37 | $0.55 | ||
| Q3 24 | $0.34 | $0.55 | ||
| Q2 24 | $0.35 | $0.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $120.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $695.7M |
| Total Assets | $6.3B | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $120.5M | ||
| Q3 25 | $1.8B | $107.0M | ||
| Q2 25 | $1.2B | $106.8M | ||
| Q1 25 | $904.9M | $107.3M | ||
| Q4 24 | $606.1M | $60.9M | ||
| Q3 24 | $621.2M | $85.1M | ||
| Q2 24 | $939.2M | $82.5M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $695.7M | ||
| Q3 25 | $2.7B | $687.3M | ||
| Q2 25 | $2.6B | $685.5M | ||
| Q1 25 | $2.3B | $679.2M | ||
| Q4 24 | $2.1B | $629.0M | ||
| Q3 24 | $2.0B | $611.8M | ||
| Q2 24 | $2.4B | $596.3M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.3B | ||
| Q3 25 | $7.5B | $3.2B | ||
| Q2 25 | $7.3B | $3.1B | ||
| Q1 25 | $6.8B | $3.0B | ||
| Q4 24 | $6.5B | $2.6B | ||
| Q3 24 | $6.4B | $2.6B | ||
| Q2 24 | $6.8B | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $41.6M |
| Free Cash FlowOCF − Capex | — | $24.0M |
| FCF MarginFCF / Revenue | — | 2.0% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | — | 2.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $41.6M | ||
| Q3 25 | $659.9M | $118.4M | ||
| Q2 25 | $303.0M | $7.8M | ||
| Q1 25 | $183.8M | $137.7M | ||
| Q4 24 | $301.4M | $-61.9M | ||
| Q3 24 | $199.5M | $106.2M | ||
| Q2 24 | $279.4M | $15.0M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $24.0M | ||
| Q3 25 | $579.4M | $97.9M | ||
| Q2 25 | $208.9M | $-10.4M | ||
| Q1 25 | $96.8M | $127.2M | ||
| Q4 24 | $176.8M | $-74.0M | ||
| Q3 24 | $88.3M | $88.3M | ||
| Q2 24 | $213.3M | $613.0K |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 2.0% | ||
| Q3 25 | 47.9% | 8.4% | ||
| Q2 25 | 18.1% | -0.9% | ||
| Q1 25 | 9.3% | 10.8% | ||
| Q4 24 | 15.9% | -6.9% | ||
| Q3 24 | 8.9% | 8.3% | ||
| Q2 24 | 21.2% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.5% | ||
| Q3 25 | 6.7% | 1.8% | ||
| Q2 25 | 8.1% | 1.6% | ||
| Q1 25 | 8.4% | 0.9% | ||
| Q4 24 | 11.2% | 1.1% | ||
| Q3 24 | 11.2% | 1.7% | ||
| Q2 24 | 6.6% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 2.11× | ||
| Q3 25 | 2.33× | 8.96× | ||
| Q2 25 | 1.69× | 0.50× | ||
| Q1 25 | 1.74× | 5.56× | ||
| Q4 24 | 1.99× | -2.00× | ||
| Q3 24 | 1.48× | 3.44× | ||
| Q2 24 | 1.95× | 0.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
